Clinical Trial Update: Clinical Trial Evaluating TQB6411 Injection in Subjects With Esophageal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating TQB6411 injection in patients with esophageal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• TQB6411

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Esophageal Cancer | Phase 1, Phase 2 | Status: RECRUITING